Bionomics Accumulated Other Comprehensive Income from 2010 to 2024

BNOX Stock  USD 0.28  0.01  3.45%   
Bionomics Accumulated Other Comprehensive Income yearly trend continues to be fairly stable with very little volatility. Accumulated Other Comprehensive Income is likely to outpace its year average in 2024. Accumulated Other Comprehensive Income is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. View All Fundamentals
 
Accumulated Other Comprehensive Income  
First Reported
2003-03-31
Previous Quarter
-3 M
Current Value
-2.4 M
Quarterly Volatility
5.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.37. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Accumulated Other Comprehensive Income Growth Pattern

Below is the plot of the Accumulated Other Comprehensive Income of Bionomics Ltd ADR over the last few years. It is gains and losses not included in net income that are recorded in shareholders' equity, reflecting changes in the value of assets or liabilities that are not realized. Bionomics' Accumulated Other Comprehensive Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
Accumulated Other Comprehensive Income10 Years Trend
Very volatile
   Accumulated Other Comprehensive Income   
       Timeline  

Bionomics Accumulated Other Comprehensive Income Regression Statistics

Arithmetic Mean6,067,536
Coefficient Of Variation92.29
Mean Deviation4,802,300
Median8,594,504
Standard Deviation5,600,030
Sample Variance31.4T
Range17.1M
R-Value0.04
Mean Square Error33.7T
R-Squared0
Significance0.89
Slope47,357
Total Sum of Squares439T

Bionomics Accumulated Other Comprehensive Income History

2024-2.9 M
2023-3 M
20229.7 M
20218.6 M
20208.6 M
20199.2 M
20189.6 M

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Accumulated Other Comprehensive Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-3 M-2.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.